Sarcoidosis in India: Practical issues and difficulties in diagnosis and management

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 19, Issue 3, 2002, Pages 176-184

  Jindal, Surinder Kumar ^a   Gupta, Dheeroy ^a   Aggarwal, Ashutash Nath ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Granulomatous disease; India; Pulmonary fibrosis; Sarcoidosis; Tropical countries

Indexed keywords

ANALGESIC AGENT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; BUDESONIDE; CALCITONIN; CALCIUM; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEFLAZACORT; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PREDNISOLONE; THALIDOMIDE; VITAMIN D;

CLINICAL FEATURE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INDIA; LUNG BIOPSY; OSTEOPOROSIS; PEPTIC ULCER; PRIORITY JOURNAL; RELAPSE; SARCOIDOSIS; SIDE EFFECT; SKIN DISEASE; THORAX RADIOGRAPHY; TUBERCULOSIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; INDIA; SARCOIDOSIS, PULMONARY; TUBERCULOSIS, PULMONARY;

EID: 0036791635     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (104)

1. Sharma OP: Epidemiology, In: Sarcoidosis: Clinical Management. London: Butterworth & Co., 1984: 4-7.
2. Hosoda Y, Kosuda T, Yamamoto M, et al: A cooperative study of sarcoidosis in Asia and Africa: descriptive epidemiology. Ann N Y Acad Sci 1976; 278: 347-54.
3. Gupta SK: The first published case of sarcoidosis in India. J Assoc Physicians India 1988; 36: 676-7.
4. Jindal SK, Gupta D, Aggarwal AN: Sarcoidosis in developing countries. Curr Opin Pulm Med 2000; 6: 448-54.
5. Gupta SK: Clinical profile of sarcoidosis in Eastern India. Indian J Chest Dis Allied Sci 1981; 23: 173-8.
6. Singh RB, Babu KS: Pulmonary sarcoidosis in a south Indian hospital: clinical and lung function profile. Indian J Chest Dis Allied Sci 1999; 41: 145-51.
7. Kim DS. Sarcoidosis in Korea: report of the Second Nationwide Survey. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 176-80.
8. Bambery P, Behera D, Gupta AK, et al: Sarcoidosis in North India: the clinical profile of 40 patients. Sarcoidosis 1987; 4: 155-8.
9. Samman Y, Ibrahim M, Wali S: Sarcoidosis in the western region of Saudi Arabia. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 215-8.
10. Liam CK, Menon A: Sarcoidosis: a review of cases seen at the University Hospital, Kuala Lumpur. Singapore Med J 1993; 34: 153-6.
11. Gothi GD, Chakraborty AK, Nair SS, Ganapathy KT, Banerjee GC: Prevalence of tuberculosis in a South Indian district-twelve years after initial survey. Indian J Tuberc 1979; 26: 120-33.
12. Mohan A, Sharma SK: Epidemiology. In: Sharma SK, Mohan A ed. Tuberculosis. New Delhi: Jaypee Brothers, 2001: 14-29.
13. Almenoff PL, Johnson A, Lesser M, Mattman LH: Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996; 51: 530-3.
14. Saboor SA, Johnson NM, McFadden J: Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992; 339: 1012-5.
15. Mitchell IC, Turk JL, Mitchell DN: Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet 1992; 339: 1015-7.
16. Hance AJ: The role of mycobacteria in the pathogenesis of sarcoidosis. Semin Respir Infect 1998; 13: 197-205.
17. Wilsher ML, Menzies RE, Croxson MC: Mycobacterium tuberculosis DNA in tissues affected by sarcoidosis. Thorax 1998; 53: 871-4.
18. Graham DY, Markesich DC, Kalter DC, Moss MT, Hermon-Taylor J, el-Zaatari FA: Mycobacterial aetiology of sarcoidosis. Lancet 1992; 340: 52-3.
19. Richter E, Kataria YP, Zissel G, Homolik J, Schlaak M, Muller-Quernheim J. Analysis of the Kveim-Siltzbach test reagent for bacterial DNA. Am J Respir Crit Care Med 1999; 159: 1981-4.
20. Kataria YP, Holter JF: Immunology of sarcoidosis. Clin Chest Med 1997; 18: 719-39.
21. McGrath DS, Goh N, Foley PJ, du Bois RM: Sarcoidosis: genes and microbes - soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 149-64.
22. Lynch JP III, Sharma OP, Baughman RP: Extrapulmonary sarcoidosis. Semin Respir Infect 1998; 13: 229-54.
23. Woodring JH, Vandiviere HM, Fried AM, Dillon ML, Williams TD, Melvin IG: Update: the radiographic features of pulmonary tuberculosis. Am J Roentgenol 1986; 146: 497-506.
24. Deremee RA: The roentgenographic staging of sarcoidosis: Historic and contemporary perspectives. Chest 1983; 83: 128-33.
25. Chugh IM, Agarwal AK, Arora VK, Shah A: Bilateral miliary pattern in sarcoidosis. Indian J Chest Dis Allied Sci 1997; 39: 245-9.
26. Gupta D, Kumar R, Jindal SK: Bilateral miliary mottling without hilar lymphadenopathy; a rare presentation of sarcoidosis. Lung India 1996; 14: 87-8.
27. Sharma SK, Mohan A, Pande JN, Prasad KL, Gupta AK, Khilnani GC: Clinical profile, laboratory characteristics and outcome in miliary tuberculosis. QJM 1995; 88: 29-37.
28. Hatzakis K, Siafakas NM, Bouros D: Miliary sarcoidosis following miliary tuberculosis. Respiration 2000; 67: 219-22.
29. Rizzato G, Montemurro L: The clinical spectrum of the sarcoid peripheral lymph node. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 71-80.
30. Dandapat MC, Mishra BM, Dash SP, Kar PK: Peripheral lymph node tuberculosis: a review of 80 cases. Br J Surg 1990; 77: 911-12.
31. Radhika S, Gupta SK, Chakrabarti A, Rajwanshi A, Joshi K: Role of culture for mycobacteria in fine-needle aspiration diagnosis of tuberculous lymphadenitis. Diagn Cytopathol 1989; 5: 260-2.
32. Gupta AK, Nayar M, Chandra M: Critical appraisal of fine needle aspiration cytology in tuberculous lymphadenitis. Acta Cytol 1992; 36: 391-4.
33. Sharma OP: Cutaneous sarcoidosis: clinical features and management. Chest 1972; 61: 320-5.
34. Mammen A, Thambiah AS: Tuberculosis of the skin. Ind J Dermatol Venereol 1973; 39: 153-9.
35. Sehgal VN, Jain MK, Srivastava G: Changing pattern of cutaneous tuberculosis. A prospective study. Int J Dermatol 1989; 28: 231-6.
36. Kumar B, Muralidhar S: Cutaneous tuberculosis: a twenty-year prospective study. Int J Tuberc Lung Dis 1999; 3: 494-500.
37. James DG: Ocular sarcoidosis. Ann N Y Acad Sci 1986; 465: 551-63.
38. Craig JH, Holland GN: Ocular tuberculosis. Surv Ophthalmol 1993; 38: 229-56.
39. Agrawal PK, Nath J, Jain BS: Orbital involvement in tuberculosis. Indian J Ophthalmol 1977; 25: 12-16.
40. Garg SP, Venkatesh P: Ocular tuberculosis. In: Sharma SK, Mohan A ed. Tuberculosis. New Delhi: Jaypee Brothers 2001; 294-303.
41. Gulati M, Suri S, Kaur G, Jindal SK, Behera D: CT manifestations of tubercular mediastinal lymphadenopathy. Indian J Chest Dis Allied Sci 1994; 36: 3-7.
42. Jindal SK, Gupta D: Algorithm for diagnosing pulmonary fibrosis in tropical countries. Curr Opin Pulm Med 1998; 4: 294-9.
43. Israel HL, Sones M: Sarcoidosis, tuberculosis, and tuberculin anergy. A prospective study. Am Rev Respir Dis 1966; 94: 887-95.
44. Trial of BCG vaccines in south India for tuberculosis prevention. Indian J Med Res 1979; 70: 349-63.
45. Trial of BCG vaccines in south India for tuberculosis prevention: first report - Tuberculosis Prevention Trial. Bull World Health Organ 1979; 57: 819-27.
46. Gupta D, Saiprakash BV, Aggarwal AN, Muralidhar S, Kumar B, Jindal SK: Value of different cut-off points of tuberculin skin test to diagnose tuberculosis among patients with respiratory symptoms in a Chest Clinic. J Ass Phy India 2001; 49: 332-5.
47. Jindal SK, Gupta D: Incidence and recognition of interstitial pulmonary fibrosis in developing countries. Curr Opin Pulm Med 1997; 3: 378-83.
48. Gilman MJ, Wang KP: Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980; 122: 721-4.
49. Gupta D, Behera D, Joshi K, Jindal SK: Role of fiberoptic bronchoscopy (transbronchial lung biopsy) in diagnosis of parenchymatous lung disease. J Ass Phy India 1997; 45: 371-3.
50. Torrington KG, Shorr AF, Parker JW: Endobronchial disease and racial differences in pulmonary sarcoidosis. Chest 1997; 111: 619-22.
51. Gupta D, Mahendran C, Aggarwal AN, Joshi K, Jindal SK: Endobronchial vis à vis transbronchial involvement on fiberoptic bronchoscopy in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 91-2.
52. Tabak L, Agirbas E, Yilmazbayhan D, Tanyeri H, Guc U: The value of labial biopsy in the differentiation of sarcoidosis from tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 191-5.
53. Siltzbach LE: Qualities and behavior of satisfactory Kveim suspensions. Ann N Y Acad Sci 1976; 278: 665-9.
54. Sharma OP: Diagnosis of sarcoidosis. Arch Intern Med 1983; 143: 1418-9.
55. Munro CS, Mitchell DN: The Kveim response: still useful, still a puzzle. Thorax 1987; 42: 321-31.
56. James DG. Sarcoidosis 2001. Postgrad Med J 2001; 77: 177-80.
57. Lieberman J: Elevation of serum angiotensin-connecting enzyme (ACE). Am J Med 1975; 59: 365-72.
58. Gupta SK, Mitra K, Chakraborty M: Serum angiotensin converting enzyme in respiratory diseases. J Assoc Physicians India 1985; 33: 651-2.
59. Sainani GS, Mahbubani V, Trikannad V: Serum angiotensin converting enzyme activity in sarcoidosis and pulmonary tuberculosis. J Assoc Physicians India 1996; 44: 29-30.
60. Brice EA, Friedlander W, Bateman ED, Kirsch RE: Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD. Chest 1995; 107: 706-10.
61. Sharma OP: Vitamin D, calcium, and sarcoidosis. Chest 1996; 109: 535-9.
62. Huang CT, Heurich AE, Rosen Y, Moon S, Lyons HA: Pulmonary sarcoidosis: roentgenographic, functional, and pathologic correlations. Respiration 1979; 37: 337-45.
63. Keogh BA, Hunninghake GW, Line BR, Crystal RG: The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function. Am Rev Respir Dis 1983; 128: 256-65.
64. Costabel U: Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 1992; 9 (suppl. 1): 211-14.
65. D'Ippolito R, Foresi A, Chetta A, et al: Induced sputum in patients with newly diagnosed sarcoidosis: comparison with bronchial wash and BAL. Chest 1999; 115: 1611-15.
66. Israel HL, Albertine KH, Park CH, Patrick H: Whole-body gallium 67 scans. Role in diagnosis of sarcoidosis. Am Rev Respir Dis 1991; 144: 1182-6.
67. Gupta D, Jorapur V, Bambery P, Joshi K, Jindal SK: Pulmonary sarcoidosis: spirometric correlation with transbronchial biopsy. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 77-80.
68. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS: Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 1995; 107: 323-9.
69. Pietinalho A, Ohmichi M, Lofroos AB, Hiraga Y, Selroos O. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy proven cases. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 158-66.
70. Gupta SK: Treatment of sarcoidosis patients by steroid aerosol: a ten-year prospective study from Eastern India. Sarcoidosis 1989; 6: 51-4.
71. Kashyap S, Kumar M, Pal LS, Saini V: Clinical profile of sarcoidosis in Himachal Pradesh, Northern India. J Assoc Physicians India 1997; 45: 374-5.
72. Judson MA: An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment. Chest 1999; 115: 1158-65.
73. Johns CJ, Michele TM: The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 1999; 78: 65-111.
74. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
75. Harkleroad LE, Young RL, Savage PJ, Jenkins DW, Lordon RE: Pulmonary sarcoidosis. Long-term follow-up of the effects of steroid therapy. Chest 1982; 82: 84-7.
76. Hoyle C, Smyllie H, Leak D: Prolonged treatment of pulmonary sarcoidosis with corticosteroids. Thorax 1967; 22: 519-24.
77. Johns CJ, Zachary JB, Ball WC Jr: A ten-year study of corticosteroid treatment of pulmonary sarcoidosis. Johns Hopkins Med J 1974; 134: 271-83.
78. Gibson GJ: Sarcoidosis: old and new treatments. Thorax 2001; 56: 336-9.
79. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H: Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997; 111: 623-31.
80. Gibson GJ, Prescott RJ, Muers MF, et al: British Thoracic Society Sarcoidosis study: effects of long term corticosteroids treatment. Thorax 1996; 51: 238-47.
81. Winterbauer RH, Kraemer KG: The infectious complications of sarcoidosis: a current perspective. Arch Intern Med 1976; 136: 1356-62.
82. Sharma SK, Mohan A, Guleria R, Padhy AK: Diagnostic dilemma: tuberculosis? Or, sarcoidosis? Indian J Chest Dis Allied Sci 1997; 39: 119-23.
83. Lillebaek T, Thomsen VO: A patient with suspected sarcoidosis died from miliary tuberculosis. Scand J Infect Dis 2000; 32: 218-20.
84. Baughman RP, Lower EE, Lynch JP: Treatment modalities for sarcoidosis. Clin Pulm Med 1994; 1: 223-31.
85. Sharma OP, Colp C, Williams MH Jr: Course of pulmonary sarcoidosis with and without corticosteroid therapy as determined by pulmonary function studies. Am J Med 1966; 41: 541-51.
86. Siltzbach LE, Teirstein AS: Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand Suppl 1964; 425: 302-8.
87. Baltzan M, Mehta S, Kirkham TH, Cosio MG: Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med 1999; 160: 192-7.
88. Kataria YP: Chlorambucil in sarcoidosis. Chest 1980; 78: 36-43.
89. Suda T, Sato A, Toyoshima M, et al: Weekly low-dose methotrexate therapy for sarcoidosis. Intern Med 1994; 33: 437-40.
90. Pacheco Y, Marechal C, Marechal F, Biot N, Perrin Fayolle M: Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis 1985; 2: 107-13.
91. Baughman RP, Lower EE: Steroid-sparing alternative treatments for sarcoidosis. Clin Chest Med 1997; 18: 853-64.
92. Lynch JP III, McCune WJ: Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med 1997; 155: 395-420.
93. Baughman RP, Winget DB, Lower EE: Methotrexate is steroid sparing in acute sarcoidosis: results of a double-blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 60-6.
94. Baughman RP, Ohmichi M, Lower EE: Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 133-7.
95. Selroos O: Inhaled corticosteroids and pulmonary sarcoidosis. Sarcoidosis 1988; 5: 104-5.
96. Pietinalho A, Tukiainen P, Haahtela T, Persson T, Selroos O: Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group. Chest 1999; 116: 424-31.
97. Alberts C, van der Mark TW, Jansen HM: Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis. Eur Respir J 1995; 8: 682-8.
98. Milman N, Graudal N, Grode G, Munch E: No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study. J Intern Med 1994; 236: 285-90.
99. Rizzato G, Montemurro L, Colombo P: The late follow-up of chronic sarcoid patients previously treated with corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 52-8.
100. Spratling L, Tenholder MF, Underwood GH, Feaster BL, Requa RK: Daily vs alternate day prednisone therapy for stage II sarcoidosis. Chest 1985; 88: 687-90.
101. Rizzato G, Riboldi A, Imbimbo B, Torresin A, Milani S: The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis. Respir Med 1997; 91: 449-60.
102. Agbogu BN, Stern BJ, Sewell C, Yang G: Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995; 52: 875-9.
103. Montemurro L, Schiraldi G, Fraioli P, Tosi G, Riboldi A, Rizzato G: Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 1991; 49: 71-6.
104. Padilla ML, Schilero GJ, Teirstein AS: Sarcoidosis and transplantation. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 16-22.